QIAGEN Receives U.S. Department of Defense Contract to Further Expand Production Capacity for NeuMoDx
GERMANTOWN, Md. & HILDEN, Germany–(BUSINESS WIRE)–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it had won a U.S. government contract to increase the production capacity for consumables used on its NeuMoDx 96 and 288 integrated PCR testing systems, an important step to support laboratory testing as the COVID-19 pandemic continues.
URL link to full story
https://www.businesswire.com/news/home/20210930005979/en/QIAGEN-Receives-U.S.-Department-of-Defense-Contract-to-Further-Expand-Production-Capacity-for-NeuMoDx
Media Contact
Raymond Blanchard
(240) 686-7300